Figure 1. Anti-GBM antibody levels from start of immunoadsorption until end of observation.
Mean values ± standard deviation of all patients measured with ELISA depicted. Grey area denotes negativity of the assay.
Mean values ± standard deviation of all patients measured with ELISA depicted. Grey area denotes negativity of the assay.